TerminatedPhase 1NCT00126971

Chlorproguanil-Dapsone in Pregnant Women

Studying Malaria

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centers for Disease Control and Prevention
Principal Investigator
Robert D Newman, MD, MPH
Centers for Disease Control and Prevention
Intervention
chlorproguanil-dapsone(drug)
Enrollment
132 target
Eligibility
15-49 years · FEMALE
Timeline
2005

Study locations (1)

Collaborators

Malaria Research and Training Center, Bamako, Mali · Liverpool School of Tropical Medicine

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00126971 on ClinicalTrials.gov

Other trials for Malaria

Additional recruiting or active studies for the same condition.

See all trials for Malaria →

← Back to all trials